Impact of minimal residual disease prior to conditioning and chimerism after BMT in childhood acute lymphoblastic leukaemia.

被引：0
|
作者：
Hancock, J
Goulden, N
Oakhill, A
Ferris, V
Moppett, J
Burke, A
Garland, R
Groves, S
Cornish, J
Pamphilon, D
Steward, C
机构：
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Royal Hosp Sick Children, Bristol BS2 8BJ, Avon, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2818
引用
收藏
页码：673A / 673A
页数：1
相关论文
共 50 条
  • [21] ASSESSMENT OF CHIMERISM AND MINIMAL RESIDUAL DISEASE (MRD) AFTER UNRELATED DONOR (UD) BMT FOR CHILDHOOD ALL
    GOULDEN, N
    MOLLOY, K
    LANGLANDS, K
    LAWLER, M
    STEWARD, CG
    PAMPHILON, D
    CORNISH, J
    POTTER, M
    MCCANN, SR
    OAKHILL, A
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 688 - 688
  • [22] Prognostic value of gender for childhood acute lymphoblastic leukaemia.
    Valsecchi, MG
    Silvestri, D
    Conter, V
    Aricò, M
    Balter, R
    Barisone, E
    Binda, S
    Casale, F
    De Rossi, G
    Lo Nigro, L
    Pierani, P
    Rizzari, C
    Rondelli, R
    Santoro, N
    Testi, AM
    Zanazzo, GA
    Masera, G
    BLOOD, 1999, 94 (10) : 224B - 225B
  • [23] Unrelated donor BMT for children with Philadelphia positive acute lymphoblastic leukaemia.
    Marks, DI
    Bird, JM
    Cornish, JM
    Pamphilon, DH
    Steward, CG
    Oakhill, A
    BLOOD, 1997, 90 (10) : 4535 - 4535
  • [24] IMPACT OF MINIMAL RESIDUAL DISEASE ASSESSMENT ON OUTCOMES IN A COHORT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
    Das, Shreyasi
    Mahajan, Amita
    Dhingra, Himani
    Mukherjee, Swetlana
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [25] Modelling a minimal residual disease-based treatment strategy in childhood acute lymphoblastic leukaemia
    Campbell, PJ
    Morley, AA
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 30 - 38
  • [26] Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia
    Schraw, Jeremy M.
    Junco, Jacob J.
    Brown, Austin L.
    Scheurer, Michael E.
    Rabin, Karen R.
    Lupo, Philip J.
    EBIOMEDICINE, 2019, 48 : 49 - 57
  • [27] Cerebral thromboses during treatment of childhood acute lymphoblastic leukaemia.
    Pautard, B
    Micheli, J
    Auclerc, MF
    Te, VLT
    Leblanc, T
    Horle, B
    Parker, JL
    Schmitt, C
    Michel, G
    Schneider, P
    Margueritte, G
    Notz, A
    Gandemer, V
    Leverger, G
    Baruchel, A
    BLOOD, 2005, 106 (11) : 257A - 257A
  • [28] MHC class III polymorphisms in childhood acute lymphoblastic leukaemia.
    Dorak, MT
    Mills, K
    Burnett, AK
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 68 - 68
  • [29] Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
    Sutton, Rosemary
    Venn, Nicola C.
    Tolisano, Jonathan
    Bahar, Anita Y.
    Giles, Jodie E.
    Ashton, Lesley J.
    Teague, Lochie
    Rigutto, Gemma
    Waters, Keith
    Marshall, Glenn M.
    Haber, Michelle
    Norris, Murray D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (03) : 292 - 299
  • [30] Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react
    Pochon, Cecile
    Oger, Emmanuel
    Michel, Gerard
    Dalle, Jean-Hugues
    Salmon, Alexandra
    Nelken, Brigitte
    Bertrand, Yves
    Cave, Helene
    Cayuela, Jean-Michel
    Grardel, Nathalie
    Macintyre, Elizabeth
    Margueritte, Genevieve
    Mechinaud, Francoise
    Rohrlich, Pierre
    Paillard, Catherine
    Demeocq, Francois
    Schneider, Pascale
    Plantaz, Dominique
    Poiree, Marilyne
    Eliaou, Jean-Francois
    Semana, Gilbert
    Drunat, Severine
    Jonveaux, Philippe
    Bordigoni, Pierre
    Gandemer, Virginie
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (02) : 249 - 261
12345